PineBridge Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,724
Closed -$328K 540
2025
Q3
$328K Sell
5,724
-2,356
-29% -$136K ﹤0.01% 514
2025
Q2
$477K Sell
8,080
-1,980
-20% -$128K ﹤0.01% 516
2025
Q1
$736K Sell
10,060
-22,343
-69% -$1.85M 0.01% 577
2024
Q4
$2.68M Buy
32,403
+9,695
+43% +$765K 0.02% 470
2024
Q3
$1.62M Buy
+22,708
New +$1.6M 0.01% 550
2023
Q3
Sell
-1,106
Closed -$65.9K 816
2023
Q2
$65.9K Buy
+1,106
New +$63K ﹤0.01% 612
2022
Q2
Sell
-40,532
Closed -$2.99M 752
2022
Q1
$2.99M Buy
40,532
+3,621
+10% +$252K 0.03% 354
2021
Q4
$2.67M Buy
+36,911
New +$2.68M 0.03% 380

Other funds holding GMED

PineBridge Investments's GMED Position: Q4 2025 in Review

PineBridge Investments sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 5,724 shares — an estimated $328K sold.

PineBridge Investments first reported a position in GMED in Q4 2021 and held it in 8 quarters. The position peaked at $2.99M in Q1 2022. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • PineBridge Investments reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • PineBridge Investments sold 5,724 Globus Medical shares in Q4 2025, an estimated $328K.
  • PineBridge Investments first reported a position in Globus Medical in Q4 2021 and held it in 8 quarters.
  • PineBridge Investments's Globus Medical position peaked at $2.99M in Q1 2022.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on PineBridge Investments's 13F filing for Q4 2025, filed 11 Feb 2026.